Hsiao D Lieu's Net Worth

$256 Thousand

Estimate Recalculated Sep 9, 2024 12:37AM EST

Who is Hsiao D Lieu

Hsiao D Lieu does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NGM BIOPHARMACEUTICALS INC, and Nile Therapeutics, Inc..

SEC CIK

Hsiao D Lieu's CIK is 0001468482

Past Insider Trading and Trends

2023 was Hsiao D Lieu's most active year for acquiring shares with 7 total transactions. Hsiao D Lieu's most active month to acquire stocks was the month of February. 2024 was Hsiao D Lieu's most active year for disposing of shares, totalling 9 transactions. Hsiao D Lieu's most active month to dispose stocks was the month of March. 2021 saw Hsiao D Lieu paying a total of $120,600.00 for 110,000 shares, this is the most they've acquired in one year. In 2021 Hsiao D Lieu cashed out on 22,258 shares for a total of $283,934.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NGM BIOPHARMACEUTICALS INC

Chief Medical Officer
Updated Apr 08, 2024
Form 4
-100.00%
-833.10K
Apr 08, 2024
Disposition
Apr 05
Form 4
-9.10%
-5.43K
$1.34
-$7.28K
Jan 18, 2024
54.25K
Tax
Jan 16
Form 4
Nov 08, 2023
615.00K
Acq/Dis
Nov 06
Form 4
8,138.20%
212.00K
Mar 06, 2023
214.61K
Grant
Mar 02
Form 4
150.00K
Nov 08, 2022
150.00K
Grant
Nov 04
Form 4
150.00K
Mar 04, 2022
150.00K
Grant
Mar 03
Form 4
-1.04%
-2.00K
$17.03
-$19.88K
Oct 07, 2021
190.00K
Sale
ScheduledOct 05
Form 4
-5.07%
-10.26K
$17.73
-$143.45K
Aug 13, 2021
192.00K
Sale
Aug 11 - Aug 12
Form 4
100.00K
Mar 18, 2021
100.00K
Grant
Mar 17
Form 4
-89.56%
-1.56K
$22.00
-$34.36K
May 18, 2020
182.00
Sale
May 15
Form 3/A
May 18, 2020
1.56K
Form 3
Apr 14, 2020
Showing 12 results

Nile Therapeutics, Inc.

Executive VP, Clinical Dev.
Updated Apr 02, 2012
Form 4
21,875.00%
21.88K
Apr 02, 2012
628.14K
Purchase
Mar 30
Form 4
100.00K
May 27, 2011
606.27K
Grant
May 26
Form 4
26.86%
27.19K
Jan 05, 2011
506.27K
Grant
Jan 03
Form 4
115.62%
25.00K
Dec 21, 2010
479.08K
Grant
Dec 17
Form 4
100.00K
Jul 12, 2010
454.08K
Grant
Jul 08
Form 4
170.00%
63.75K
Feb 17, 2010
353.98K
Grant
Feb 15
Form 4
137.02%
12.50K
Jan 21, 2010
290.23K
Grant
Jan 19
Form 4
277.73K
$4.60
$460.00
Jul 20, 2009
277.73K
Purchase
Mar 10 - Jul 07
Form 3
Jul 20, 2009
Showing 9 results